Bronchodilator Therapy

Tests of Bronchodilator Therapy

cavities is rarely reported, and”.. . such a communication was demonstrable [only] at necropsy.”1( ’200) A few years ago, we2 reported three cases of pancreaticopleural fistula demonstrated by the early injection of iodized oil (Lipiodol) into the pleural cavity. In an additional case, we have demonstrated a large communication between the pleural cavity and a pancreatic pseudocyst (Fig 1). We ...

Combination bronchodilator therapy in COPD.

Dual bronchodilator therapy: A review

Inhaled bronchodilators with or without inhaled steroids (IGCs) are the mainstay of pharmacological treatment for stable obstructive airway diseases, including beta2agonists and muscarinic antagonists. Long-acting muscarinic antagonist bronchodilators (LAMA) and long-acting β2-agonists (LABA) are the treatment of choice for moderate to severe chronic obstructive pulmonary disease (COPD). Also, ...

Bronchodilator therapy and hyperactivity in preschool children.

The common report of parents of asthmatic children that inhaled/nebulised salbutamol causes overactive behaviour was investigated. Nineteen children were assessed in a standardised setting before and after the administration of nebulised salbutamol and placebo. Neither parental report nor observer ratings suggested any significant increase in the child's level of activity.

Bronchodilator therapy in COPD: physiological effects

Bronchodilator therapy is the first step in improving dyspnoea and exercise endurance in patients with COPD. Recent studies have challenged the long-held view that airway obstruction in COPD is irreversible. We now know that even in the setting of minor or no change in traditional spirometry, bronchodilator therapy is associated with consistent, and often impressive, reduction in lung hyperinfl...